Last reviewed · How we verify
NCT04152369: ESBL
"Peri-operative Antimicrobial Prophylaxis in Patients With Asymptomatic Bacteriuria of Enterobacteriacae ESBL+ Origin"
NA trial testing Anti-microbial prophylaxis for an endourological procedure or ESWL in Antimicrobial Prophylaxis in 70 participants. Status unknown.
30 June 2020
Quick facts
| Lead sponsor | Military Institute od Medicine National Research Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 70 |
| Start date | 15 July 2016 |
| Primary completion | 30 June 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Anti-microbial prophylaxis for an endourological procedure or ESWL
Conditions studied
- Antimicrobial Prophylaxis — all drugs for Antimicrobial Prophylaxis →
- Asymptomatic Bacteriuria — all drugs for Asymptomatic Bacteriuria →
Sponsor
Military Institute od Medicine National Research Institute
Who can join
18 and older, any sex, with Antimicrobial Prophylaxis or Asymptomatic Bacteriuria. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to determine optimal safe duration of antibiotic prophylaxis in patients undergoing endourological procedures and ESWL, presenting with asymptomatic bacteriuria caused by multi-drug resistant bacterial strains. In this study we compare safety and efficacy of a one-day vs. three-day AMP (Antimicrobial Prophylaxis) in the above mentioned group of patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing <i>Enterobacterales</i> bacteriuria scheduled for urological procedures.
Radko M, Guzek A, Syryło T, Rybicki Z, et al · · 2022 · cited 1× · PMID 35937654 · DOI 10.5173/ceju.2022.0109
Verify or expand the search:
- PubMed search for NCT04152369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Military Institute od Medicine National Research Institute trials
Trials by the same sponsor.
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT07395180 — Differentiation of Human Body Balance Disorders · NA · active not recruiting
- NCT06012552 — Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fo · Phase 2 · recruiting
- NCT05716880 — Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome · Phase 3 · recruiting
- NCT05516160 — Perceptually Calibrated Scale of Optical Aberrations · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04152369 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Military Institute od Medicine National Research Institute
- Last refreshed: 20 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04152369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing